Y, Z., N, W., X, S., G, D., Q, X., H, Y., & Y, S. (2025). Erratum: Author correction to "Celastrol targets adenylyl cyclase-associated protein 1 to reduce macrophages-mediated inflammation and ameliorates high fat diet-induced metabolic syndrome in mice" [Acta Pharm Sin B 11 (2021) 1200-1212]. Acta pharmaceutica Sinica. B, 15(3), 1719. https://doi.org/10.1016/j.apsb.2024.12.009
Chicago Style (17th ed.) CitationY, Zhu, Wan N, Shan X, Deng G, Xu Q, Ye H, and Sun Y. "Erratum: Author Correction to "Celastrol Targets Adenylyl Cyclase-associated Protein 1 to Reduce Macrophages-mediated Inflammation and Ameliorates High Fat Diet-induced Metabolic Syndrome in Mice" [Acta Pharm Sin B 11 (2021) 1200-1212]." Acta Pharmaceutica Sinica. B 15, no. 3 (2025): 1719. https://doi.org/10.1016/j.apsb.2024.12.009.
MLA (9th ed.) CitationY, Zhu, et al. "Erratum: Author Correction to "Celastrol Targets Adenylyl Cyclase-associated Protein 1 to Reduce Macrophages-mediated Inflammation and Ameliorates High Fat Diet-induced Metabolic Syndrome in Mice" [Acta Pharm Sin B 11 (2021) 1200-1212]." Acta Pharmaceutica Sinica. B, vol. 15, no. 3, 2025, p. 1719, https://doi.org/10.1016/j.apsb.2024.12.009.